Patents by Inventor Philip R. Kym

Philip R. Kym has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucocortiocoid-selective antinflammatory agents
    Patent number: 6506766
    Abstract: Compounds having Formula I are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.
    Type: Grant
    Filed: July 5, 2000
    Date of Patent: January 14, 2003
    Assignees: Abbott Laboratories, Ligand Pharmaceuticals Incorporated
    Inventors: Michael J. Coghlan, James P. Edwards, Steven W. Elmore, Todd K. Jones, Michael E. Kort, Philip R. Kym, Jimmie L. Moore, John K. Pratt, Alan X. Wang
  • Glucocorticoid receptor antagonists for treatment of diabetes
    Patent number: 6436986
    Abstract: The instant invention relates to compounds of formula I which are useful as antagonists of the glucocorticoid receptor and for treating diabetes in a mammal. In addition, any glucocorticoid receptor antagonist(s) is useful for the treatment of diabetes.
    Type: Grant
    Filed: August 9, 2000
    Date of Patent: August 20, 2002
    Assignee: Abbott Laboratories
    Inventors: Philip R. Kym, Benjamin C. Lane, John K. Pratt, Tom von Geldern
  • Potassium channel openers
    Publication number: 20020028836
    Abstract: Compounds of formula I: 1
    Type: Application
    Filed: February 5, 2001
    Publication date: March 7, 2002
    Inventors: Robert J. Altenbach, Hao Bai, Jorge D. Brioni, William A. Carroll, Murali Gopalakrishnan, Robert J. Gregg, Mark W. Holladay, Peggy P. Huang, John F. Kincaid, Michael E. Kort, Philip R. Kym, John K. Lynch, Arturo Perez-Medrano, Henry Q. Zhang
  • Glucocorticoid receptor antagonists for treatment of diabetes
    Patent number: 6329534
    Abstract: Compounds of formula I are useful for treating type II diabetes, obesity, hyperglycemia, inadequate glucose clearance, hyperinsulinemia, hypertriglyceridemia, and high-circulating glucocorticoid levels, preparations of the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: December 11, 2001
    Assignee: Abbott Laboratories
    Inventors: Philip R. Kym, Benjamin C. Lane, John K. Pratt, Tom Von Geldern, Martin Winn, Jehrod Brenneman, Jyoti R. Patel, David L. Arendsen, Irini Akritopoulou-Zanze
  • Glucocorticoid receptor antagonists for treatment of diabetes
    Publication number: 20010041802
    Abstract: 1
    Type: Application
    Filed: February 28, 2001
    Publication date: November 15, 2001
    Inventors: Philip R. Kym, Benjamin C. Lane, John K. Pratt, Tom Von Geldern, Martin Winn, Jehrod Brenneman, Jyoti R. Patel, David L. Arendsen, Irini Akritopoulou-Zanze, Kimba L. Ashworth, Kresna Hartandi